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Abstract: Liquid-liquid phase separation (LLPS) is a way 
to concentrate biochemical reactions while excluding non-
interacting components. Disordered domains of proteins, 
as well as interaction with RNA, favor condensation but 
are not mandatory for modulating this process. Recent 
insights about phase-separation mechanisms pointed to 
new fascinating models that could explain how cells could 
cope with DNA damage responses, conferring both spatial 
and temporal fine regulation. APE1 is a multifunctional 
protein belonging to the Base Excision Repair (BER) 
pathway, bearing additional ‘non-canonical’ DNA-repair 
functions associated with processes like RNA metabolism. 
Recently, it has been highlighted that several DNA repair 
enzymes, such as 53BP1 and APE1, are endowed with RNA 
binding abilities. In this work, after reviewing the recent 
literature supporting a role of LLPS in DDR, we analyze, 
as a proof of principle, the interactome of APE1 using a 
bioinformatics approach to look for clues of LLPS in BER. 
Some of the APE1 interactors are associated with cellular 
processes in which LLPS has been either proved or 
proposed and are involved in different pathogenic events. 
This work might represent a paradigmatical pipeline for 
evaluating the relevance of LLPS in DDR.
Keywords: Base excision repair; bioinformatics; 
interactome; phase-separation; RNA. 
Phase separation in nuclear 
organization and functions related 
to DNA damage response
Nuclear dynamics, among other crucial cellular processes, 
has been recently established to be tuned, at least in part, 
by the widespread phenomenon of phase separation 
[1]. After a decade of active research, it is now accepted 
that this demixing process is a thermodynamically-
driven phenomenon, giving rise to a variety of dynamic 
bodies (i.e., biomolecular condensates, BMCs), primarily 
composed of nucleic acids and proteins [2] interacting 
through quinary interactions [3], frequently involving 
unstructured portions of proteins, especially intrinsically 
disordered regions (IDRs) [4,5]. These components are 
thought to be under the control of effective regulatory 
systems, through the action of a number of cellular 
factors which precisely tune the assembly and the 
de-aggregation of these bodies via post-translational 
modifications (PTMs), thus promoting a localized 
induction of condensates [6]. Some examples of nuclear 
processes proposed to be shaped by phase separation 
are heterochromatin domain formation, transcription, 
nucleolar metabolism, and DNA damage response (DDR). 
Indeed, it has been shown that chromatin structure 
dynamics may be regulated through phase-separation 
of several proteins (e.g., HP-1 and BRD4) involved in the 
reading of epigenetic marks on histone tails [7–9]; histone 
tail-DNA interactions might have a role in this process, as 
well [9]. An outstanding example of phase separation in 
the nucleus is represented by the nucleolus, the cellular 
body devoted to ribosome biogenesis. In recent years, it 
has been demonstrated that nucleoli may arise by phase 
separation induced by transcription of rRNAs from their 
genomic loci [10,11] and that their three layers constitute 
an example of nested phase-separated domains [12]: 
indeed these domains, namely the fibrillar center, the 
dense fibrillar component and the granular component, 
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each contributing to ribogenesis through different steps 
of rRNA maturation and ribosome assembling, although 
sharing the rRNA as a major phase separating agent and 
being in direct interaction, do not mix and preserve their 
functional specificity as a consequence of the biophysical 
properties of the components [12]. An additional process, 
for which a phase separation mechanism has been 
proposed, is represented by DNA transcription: recent 
studies have shed new light on the actual mechanism of 
recruitment of transcription factors, proposing cooperative 
kinetics to explain the effects driven by enhancers and 
super-enhancers, via demixing processes of transcription 
factors themselves [13,14]. However, transcription 
and other processes claimed to be driven by phase 
separation (e.g. heterochromatinization) remain to be 
fully characterised because they differ from biomolecular 
condensates in some aspects, which are reviewed in [1]. 
In particular, some compartments, characterized by many 
phase-separating features, do not strictly respect the 
canonical features of liquid biocondensates (namely the 
round shape, no shear elasticity, and internal dynamics), 
raising the question of whether phase-separation could 
be displayed in several different aspects. For example, 
paraspeckles, although regarded as demixed bodies upon 
NEAT1 increase, show a one-axis preferential growth, 
unusual for LLPS-based granules. Heterochromatic 
domains, instead, which were proposed to form by 
phase separation because of their apparent properties 
of coalescing, for excluding inert probes and for causing 
density transition in HP-1 distribution, were finally shown 
to undergo their round shape degeneration several cell 
cycles after phase separation occurred, thus denying the 
initial hypothesis [15].
Role of RNA in promoting the 
recruitment of DNA repair enzymes 
at the lesion site 
RNA is an important element of biomolecular condensates, 
and some studies demonstrated its involvement in DNA 
repair. The first evidence of this involvement was provided 
by the DDR-related action of retrotransposons in yeast: 
indeed, it was shown that retrotransposon elements might 
replace homologous sequences and become integrated at 
the lesion site [16,17]. In [18], the authors suggested an 
additional link existing between retrotransposons and 
DDR: while reverse transcriptases could promote repair 
by canonical transcripts, integrases might promote cDNA 
insertion, and cDNA might act as a template to bridge the 
double-strand break (DSB), leading to the repair by “in 
trans” or “in cis” mechanisms. Additionally, with regard 
to the repair of DSBs, it was recently suggested that Rad52 
might promote transcript-dependent DSB repair through 
inverse strand exchange, likely followed by reverse 
transcription of a ssDNA overhang [19–21]. This perspective 
is supported by the mounting evidence accounting for 
R-loops formation as a physiological regulator in the 
genome [22,23]. Notably, Rad52 (in yeast) and FUS (in 
human) were observed to contribute to the formation 
of a molecular biocondensate at DSB sites, carrying 
out different roles, namely the organization of nuclear 
microtubule filaments [24], protecting the resected end of 
lesions and promoting DNA-damage signaling [25,26], as 
well as recruiting other DSB-repair-related enzymes [27]. 
Similarly, 53BP1, which is known to be important for DSB 
signaling and to affect the progression of the cell cycle, 
was demonstrated to localize to liquid compartments 
[25,26]. 
Recently, it was found that ncRNAs seem to play a 
critical role in the formation of a liquid compartment at 
the DSB site. In detail, a novel class of RNAs has been 
defined and named DDRNAs: they are produced from 
the processing of dilncRNAs (damage-induced long non-
coding RNAs), which are transcribed at DSBs foci in a 
bidirectional manner [28,29]. DDRNAs are guided to the 
lesion site by dilncRNAs and both of them are supposed 
to contribute to the recruitment of repair enzymes [28,30]. 
Additionally, examples of the active role of lncRNAs 
promoting, in trans, the recruitment of the DSB repair 
machinery in a demixing-mediated manner have been 
described. The lncRNA LINP1, for example, allows the 
formation of a liquid department where Ku70 and Ku80 
can demix to effectively accomplish non-homologous end 
joining (NHEJ) repair [31]. In addition, other ncRNAs have 
also been associated with DDR signaling [32] and cell-
wide effects [33,34].
A typical example showing the involvement of RNA-
moiety in DDR is PARylation (and Mono ADP-ribosylation, 
MARylation), a post-translational modification consisting 
in the addition of single or multiple ADP-ribose molecules 
to both proteins and DNA [35]. These modifications are 
introduced by the PARP enzymes family and represent one 
of the main signals of genomic damage in cells [36,37]. In 
particular, PARP enzymes are now known to catalyze the 
addition of MAR or PAR moieties at single-strand break 
(SSB) and DSB loci, thus mediating the signaling of those 
damaging events [35,38]. These modifications are also 
known to direct the formation of damaged DNA-enriched 
compartments and to recruit demixing factors, like FUS 
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[39,40]. To date, albeit it is known that: i) PARP interacts 
with several BER factors (e.g., XRCC1, POLβ, and LIG3); ii) 
PARP modulates the activity of glycosylases [41,42] and 
the 3’-exonuclease activity of APE1 [43] and that iii) PARP 
inhibition significantly hampers the efficiency of the BER 
pathway [44,45], there is no evidence for the formation of 
a demixed compartment hosting the BER-mediated DDR.
Interactomes of DNA repair enzymes: 
focus on RNA processing proteins
Along with the involvement of RNA molecules themselves, 
it is widely accepted that the interaction with RNA 
represents a key feature of most DDR enzymes, both in 
direct and indirect manners. It was shown that many RNA 
binding proteins (RBPs) are required to ensure proper 
production of DDR factors (as reviewed in [46]) via post-
translational regulation of their transcripts, allowing them 
to escape the general translational repression occurring 
upon DNA damage and thus indirectly influencing the 
repair process. Nonetheless, RBPs were shown to directly 
take part in DDR, since enzymes involved in mRNA and 
miRNA processing have been associated with DNA repair. 
For instance, RBM14 is a RBP involved in alternative 
splicing and it is recruited to DSB sites via PARP1 [47,48]; 
likewise, HNRNPD is necessary for the DNA resection step 
in the homologous recombination pathway [49]. Helicases, 
for example DEAD-box helicases, are interesting RNA-
interacting proteins involved in RNA metabolism [50,51] 
and in DDR [52,53] and some of them were shown to 
participate in demixing bodies [54,55].
Interestingly, the small non-coding RNA machinery, 
including DICER and DROSHA, is also important for DSB 
repair, since its products appear to be fundamental in 
recruiting some repairing factors [29,56].
These observations collectively suggest that a strong 
involvement in RNA metabolism is common among phase 
separating factors acting in DDR and that this might be a 
key feature to be investigated.
The Apurinic/Apyrimidinic 
Endonuclease (APE1) is a crucial 
BER enzyme
The Apurinic/Apyrimidinic Endonuclease (APE1) is a 
central enzyme in the BER pathway, acting as the main 
AP-endonuclease in mammalians [57]. However, this 
enzyme was recently characterized as possessing many 
non-canonical functions (Figure 1) associated with RNA 
metabolism, including taking part in the biogenesis of 
ncRNAs (possibly through the interaction with DROSHA 
[58] or functionally interacting with other phase 
separating factors, like NPM-1 during rRNA biogenesis) 
[59], as well as with several RNA species [60]. These 
novel functions, partly supported by the capability of 
APE1 to bind to different nucleic acids, tremendously 
expand its functions toward the RNA world, which is 
clearly connected to LLPS. The ability of APE1 to bind and 
process RNA seems to be empowered by the disordered 
N-terminus of this protein, which is thought to be a recent 
evolutionary acquisition in mammals and it is found to 
be highly conserved in mammals, possibly constituting 
an important gain of function example [61]. This domain, 
in fact, was found to be essential for APE1 recruitment to 
nuclear subcompartments, including the nucleolus [62], 
and for its interaction with other BER factors [63] and 
other partners like NPM1 [61], which, in recent years, have 
also been linked to several novel functions including LLPS 
[64].
It is still not known whether the unstructured domain 
of APE1 and its RNA-binding abilities might represent an 
evolutionary gain of function to promote BER recruitment 
and to coordinate the action of the different enzymes, 
considering that every intermediate reaction product 
(i.e., the abasic site generated by glycosylases, the nick 
generated by APE1, etc.) results even more toxic than the 
original lesion processed by BER itself. This is particularly 
important, given that APE1 is much more abundant than 
all the other BER proteins and, in tumor cells, it is highly 
overexpressed. Therefore, the assumption that APE1 is 
only required for DNA repair by BER is somehow too 
limited.
Bioinformatics analysis of demixing 
proteins: the case study of the 
APE1 interactome suggests a novel 
hypothesis for triggering the Base 
Excision Repair pathway
The aforementioned features define APE1 as a reasonable 
candidate for a preliminary investigation questioning 
the involvement of a LLPS mechanism in its recruitment. 
Although there are other DDR-related, BER-involved 
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proteins, known for being central for the recruitment of 
other factors and exhibiting even multiple IDRs (e.g., 
XRCC1), nevertheless APE1 represents a particularly 
interesting subject because of its role in RNA metabolism.
Here, we propose a bioinformatics approach that 
might be employed to obtain some useful insights on 
the LLPS world, defining a pipeline to help to direct the 
following experimental activity. This pipeline employs 
the APE1 interactome we recently defined [65]. This pool 
of interactors was assessed by an unbiased pull-down 
approach, performed taking advantage of a FLAG-tagged 
APE1 recombinant form, followed by protein complexes 
characterization through a MS/MS approach. In that 
work, which allowed us to identify almost 500 APE1-PPIs, 
we intentionally used a non-targeted approach to identify 
components involved in direct APE1-protein interactions, 
as well as molecules whose interaction with APE1 is 
indirectly mediated by RNA/DNA or other proteins. This 
approach, very stringent in order to avoid misleading 
identification of protein complex elements, might 
enhance the identification of cofactors colocalizing with 
APE1 in biomolecular condensates, making this analysis 
more suited for BMCs applications. In fact, the multiple 
biological functions attributed to APE1 and its localization 
in various subcellular districts further expand the list of 
its possible protein binding partners, as deriving from 
direct or indirect interactions. The condition we observed 
for APE1 is similar to the one recently reported for two 
APE1-binding partners, namely XRCC6 and XRCC5, which 
have been similarly demonstrated binding to RNA/DNA 
and to about 300 proteins [66], or previously described 
for proteins present in chaperone machineries [67]. Other 
examples of proteins having hundreds of interactors (as 
deduced by a single immunocapture experiment) are 
already present in the scientific literature [68–70]. At the 
same time, we were aware of the relevance of the lack of 
specificity for ascertaining direct PPIs in the methodology 
we used. Nevertheless, this approach is similar to others 
already used in previous papers allowing the identification 
of original APE1-binding partners [59,71,72]. It is finally 
to be noted that about 100 APE1-PPIs (among the ones 
reported in this study) were already demonstrated to 
be real APE1-PPIs in previous studies from us or other 
research groups; important examples in this context are 
NPM1, SFPQ and hnRNPK, as proved by independent 
binding and functional assays [59,71,73,74]. 
In the first step of our proposed bioinformatics 
analysis, we retrieved the disorder content of APE1-PPIs 
Figure 1: Main APE1 functions. The main functions of APE1 are mapped to the primary structure portions responsible for such effects 
[58,73,89]. The APE1 crystal structure bound to abasic DNA is displayed starting from the PDB deposited structure (6W0Q, [90]) and was 
modified using PyMOL software. Rainbow colors: APE1 sequence; black: substrate DNA.
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from the MobiDB database (version 3.1.0) [75], which 
integrates manual reviews and in silico predictions. Out of 
515 interactors, we were able to retrieve data for about 350 
proteins (for the remaining proteins, the disorder index 
was not computed). We examined the distribution of these 
values and most of the interactors were characterized by a 
low disorder content (below 0.2) (Figure 2A).
Then, we collected the APE1-PPI data from 
PhaSePro [76], a manually curated collection of proteins 
characterized as demixing in vivo. The output consisted 
of seven APE1 interactors, namely APP, NPM1, LGALS3, 
HNRNPA1, FUS, SFPQ, and ESR1, fully characterized as 
demixing by ad hoc experiments. Their disorder content 
was pointed out as a reference in the general distribution 
(Figure 2A).
As a control, we also evaluated the disorder content 
of all the proteins profiled in the PhaSePro database 
for LLPS, focusing in particular on characterizing 
the minimum value required for partitioning and the 
dependence, if any, on demixing partners. Interestingly, 
we could define two different groups (Figure 2B): one, 
including the majority of the examined proteins, which 
showed a progressive increase in disorder content starting 
from about 0.2 and ramping up to 0.9 and a second, much 
smaller, centered on 0.05. To our surprise, the feature that 
mainly differentiated the latter was the requirement of a 
demixing partner, TIA1 representing the only exception; 
on the contrary, less than one-third of the proteins 
belonging to the first group behaved in the same way, 
with LAT curiously characterized by having the highest 
disorder content but also the necessity of a demixing 
partner. 
Considering the two distributions, we noticed that all 
the reviewed demixing proteins known for not requiring 
additional partners were basically characterized by an 
internal disorder content greater than 0.15; thus, we 
focused on the APE1 PPI having a disordered content 
above that threshold, defining a subset composed of 88 
members. We compared them to entries in PhaSepDB 
[77], which aggregates a wide range of direct and 
indirect evidence of proteins phase separation (e.g., 
fully demonstrated or just suggested by high-throughput 
data), defining a final set of 49 likely demixing interactors 
(Table 1).
To gain some insights on the biological processes 
involving these proteins, we performed a functional 
enrichment analysis [78] employing ClueGO [79], a 
Cytoscape [80] plugin allowing to use different ontologies/
databases, focusing on biological processes (Figure 3A) 
and intracellular localization (Figure 3B). 
We first analyzed the set of 49 likely demixing 
interactors defined by PhaSepDB, and the results 
highlighted 34 significantly enriched terms associated 
with six major processes by ClueGO, as shown in Figure 
3A. Interestingly, most of these terms were associated with 
gene expression and RNA processing, while the rest was 
associated with viral and telomeric regulation. 
A second analysis of the same gene set took into 
consideration the intracellular localization. We obtained 
enriched terms related to euchromatin, spliceosome, and 
translation preinitiation complex, cellular departments 
strictly linked to the metabolism of nucleic acids that, 
hence, might act as dynamic scaffolds for liquid-like 
structures (Figure 3B).
We repeated the same analysis on the seven 
interactors fully characterized as demixing by PhaSePro, 
adding APE1 as the ideal center of the functional network. 
Interestingly, one of the three enriched terms (Figure 4) 
pointed to the formation of amyloids, common hallmarks 
of neurodegenerative diseases, which have been related to 
liquid-demixing proteins [81,82].
Lastly, we compared the list of 49 interactors to the 
MSigDB database, a collection of gene sets co-expressed 
and/or involved in physiological and pathological 
processes (i.e., molecular signatures) obtained by a data 
mining approach that functionally complements the 
ontologies previously investigated using ClueGO [83,84]. 
For this investigation, the H, C4, C6 and C7 collections 
of MSigDB were chosen as terms of comparison. These 
signatures have different origins and meanings: the H 
collection is made of signatures characterizing well-
defined biological processes, C4 gathers cancer-related 
signatures originated by data mining of large microarray 
data, C6 collects signatures related to pathways 
deregulated in cancer while C7 collects signatures related 
to the immune system and its deregulation. A false 
discovery rate (FDR) threshold was set to 0.05 to establish 
significant results (Benjamini-Hochberg correction 
implemented by MSigDB). We took into account the first 
50 enriched results (Table 2).
We obtained a significant association with different 
kinds of cancer signatures, namely: liver, prostate, 
and hematological tumors; furthermore, additional 
signatures were also linked to the activation of the PBMCs 
(peripheral blood mononucleated cells). Finally, enriched 
terms also pointed to general biological processes such 
as ribogenesis, protein biosynthesis, and mRNA splicing, 
consistently with previous ClueGO results. These terms 
strongly suggest the existence of a relationship, both 
physical and functional, with: i) nucleic acids (especially 
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Figure 2: Distribution of the examined proteins disorder content. (A) APE1 protein interactors, ordered by decreasing disorder content as 
retrieved from MobiDB, are identified by their position in the list of interactors. Dashed, horizontal lines highlight the position of the APE1 
interactors known to undergo phase-separation according to PhaSePro. APE1 level of disorder is also highlighted by a red, solid line. (B) 
PhaSePro proteins, ordered by decreasing disorder content as retrieved from MobiDB, are colored according to the necessity (green) or 
independence (red) for a demixing partner. The blue dashed line highlights the 0.15 threshold in disorder content used to select proteins for 
functional characterization.
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RNA); ii) their metabolism, and iii) the compartments in 
which they accumulate.
We hypothesize that this connection might occur 
through direct or indirect recruitment to liquid demixing 
bodies, the impairment of which could be related to several 
pathological conditions. This particular association with 
nucleic acids might also represent evidence for a novel 
APE1 function related to phase-separation: on such a 
basis, more investigation is demanded to elucidate the 
possible role of biocondensates in BER pathway triggering, 
that could explain the role of these RNA-interacting 
partners, and could also be of interest for establishing 
novel protocols for drug development.
Concluding remarks
This review provides several pieces of evidence 
suggesting the involvement of new mechanisms and new 
experimentally validated protein candidates belonging to 
Table 1: List of the 49 APE1 interactors likely to undergo phase separation. These 49 interactors were identified by comparing the APE1 PPI 
network to the LLPS-oriented databases PhaSepDB and PhaSePro and characterized by an internal disorder content index (as computed by 
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the APE1 interactome in phase separating events, although 
the underlying direct or indirect molecular mechanisms 
are still to be demonstrated. 
The results here obtained, through the proposed 
bioinformatics pipeline, would be useful in further 
experimental validation to identify demixing cofactors that 
might be crucial in reproducing phase-separation in vitro 
[85]. For example, on the basis of the close relationship 
existing between APE1 and NPM1, the consequential follow 
up of this investigation could be represented by exploring 
the possible joint phase-separation of these proteins in 
the presence of rRNA, which is known to be required for 
NPM1 phase separation and that might also be necessary 
to APE1 demixing. Moreover, drugs selectively impairing 
LLPS might be employed to validate this hypothesis: 
1,6-hexanediol, for example, has been already used in 
previous works to show the demixed status of some 
bodies. Some doubts have been raised about this proving 
technique since this molecule might produce artifacts in 
living cells; in fact, its amphipathic nature is not able to 
Figure 3: Functional enrichment analysis of the set of 49 interactors likely correlated with phase separation. For each analysis, ClueGO 
identified a panel of enriched terms (adjusted pValue<0.05) that were clustered. (A) Clusters of enriched terms associated with biological 
processes involving APE1 likely demixing interactors (Queried databases: WikiPathways [66], KEGG [67], CORUM [68], ClinVar [69], 
Reactome [70], GOBiologicalProcess [71]). (B) Clusters of enriched terms (adjusted pValue<0.05) associated with subcellular localization 
(Queried database: GOCellularComponent [71]). Percent values refer to the amount of enriched terms associated with each cluster. P-values 
are referred to the clusters.
Figure 4: Functional enrichment analysis of the extended set of PhaSePro characterized proteins (including APE1). Enriched biological 
processes (adjusted pValue<0.05) interestingly suggest a role in amyloid formation, regulation of transcription and AGE receptor signaling 
(Queried databases: WikiPathways, KEGG, CORUM, ClinVar, Reactome, GOBiologicalProcess. Minimum number of genes per cluster set to 2).
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impair some of the most common molecular interactions 
giving rise to BMCs. 
We suggest that our approach may contribute to 
uncovering new molecular strategies for the therapy of 
human diseases that have been recently linked to phase 
partitioning, especially neurodegenerative diseases (e.g., 
Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), 
frontotemporal dementia). In fact, well known ALS-related 
mutations, such as substitutions in the mostly disordered 
C-terminus of TDP-43 and the hexanucleotide expansion 
in C9orf72, were shown to impair phase separation of 
these proteins, suggesting their relevance in the onset of 
the pathological condition [86,87]. Additionally, altered 
proteostasis, which leads to the formation of aggregates 
in neuronal cells, is a hallmark of such conditions and 
was related to phase separation. Nonetheless, a complete 
understanding of how this aggregation influences the 
pathological outcome is still missing and requires further 
investigation to elucidate the exact relationship linking 
the fiber formation and the toxic effect [88]. Another 
interesting question, arising from the hypothesis of 
pathological misregulation of liquid compartments, 
Table 2: The 50 most significantly enriched molecular signatures determined by the MSigDB molecular signature enrichment analysis. The 
name of the molecular signatures is provided, along with their False Discovery Rate (FDR) as computed by GSEA.
Molecular Signatures FDR
Genes in the cancer module 32. 4.13E-32
Neighborhood of ANP32B 8.23E-28
Neighborhood of ACP1 2.31E-25
Neighborhood of G22P1 5.21E-25
Neighborhood of FBL 2.39E-22
Neighborhood of DEK 6.29E-22
Neighborhood of RAN 6.55E-22
Neighborhood of GNB1 5.39E-21
Neighborhood of HDAC1 1.76E-20
A subgroup of genes regulated by MYC - version 1 
(v1).
3.04E-20
Neighborhood of EIF3S6 2.53E-19
Neighborhood of UBE2I 3.64E-19
Neighborhood of CSNK2B 1.84E-18
Neighborhood of RAD23A 1.84E-18
Neighborhood of FBL 2.3E-18
Neighborhood of ANP32B 1.53E-16
Neighborhood of BUB3 1.59E-16
Neighborhood of CCNI 6.52E-15
Neighborhood of APEX1 9.84E-15
Neighborhood of CSNK2B 1.2E-14
Genes in the cancer module 98. 1.72E-14
Genes in the cancer module 198. 2.2E-14
Neighborhood of NPM1 3.88E-14
Genes in the cancer module 83. 4.1E-14
Neighborhood of XRCC5 4.17E-14
Molecular Signatures FDR
Neighborhood of ACTG1 1.58E-13
Genes up-regulated in polymorphonuclear leukocytes 
(24h): control versus infection by A. phagocytophilum
3.46E-13
Neighborhood of ACTG1 4.38E-13
Neighborhood of SMC1L1 2.73E-12
RNA splicing. 3.93E-12
Neighborhood of TDG 4.72E-12
Neighborhood of APEX1 4.88E-12
Neighborhood of ERH 5.13E-12
Neighborhood of SOD1 9.97E-12
Neighborhood of XRCC5 1.12E-11
Neighborhood of EIF4A2 2.45E-11
Neighborhood of PCNA 2.45E-11
Neighborhood of PSME1 2.9E-11
Genes in the cancer module 151. 3.92E-11
Neighborhood of UBE2N 6.9E-11
TFs and nuclear. 7.02E-11
Protein biosynthesis and ribosomes. 7.07E-11
Neighborhood of EIF3S2 9.7E-11
Neighborhood of DEK 1.46E-10
Neighborhood of HAT1 1.74E-10
Neighborhood of HDAC1 1.99E-10
Neighborhood of ST13 2.8E-10
Neighborhood of NPM1 2.95E-10
Neighborhood of DDX5 3.01E-10
Neighborhood of DAP3 3.48E-10
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concerns how these bodies could be physiologically 
maintained and the impaired regulatory mechanisms 
leading to irreversible aggregation, if any [88]. Lastly, 
since anti-cancer therapies are partly based on inefficient 
DNA repair, further characterization of the molecular 
mechanisms and the associated dynamics, along with 
the advanced unfolding of the interactomes involved in 
such pathways, might uncover new oncological targets. 
Therefore, the uncovering of a possible LLPS-related 
mechanism would certainly improve our knowledge on 
how to target deregulated processes of the DDR, selectively 
impacting on several human pathologies.
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